Found: 18
Select item for more details and to access through your institution.
Xenin-25[LysPAL]: a novel long-acting acylated analogue of xenin-25 with promising antidiabetic potential.
- Published in:
- Acta Diabetologica, 2015, v. 52, n. 3, p. 461, doi. 10.1007/s00592-014-0681-0
- By:
- Publication type:
- Article
RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes.
- Published in:
- Diabetic Medicine, 2018, v. 35, n. 1, p. 33, doi. 10.1111/dme.13522
- By:
- Publication type:
- Article
Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 887, doi. 10.1111/dom.12508
- By:
- Publication type:
- Article
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 4, p. 403, doi. 10.1111/dom.12432
- By:
- Publication type:
- Article
Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 10, p. 891, doi. 10.1111/j.1463-1326.2010.01259.x
- By:
- Publication type:
- Article
Daily administration of the GIP-R antagonist (Pro<sup>3</sup>)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti–obesity-diabetes actions of (Pro<sup>3</sup>)GIP.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, n. 4, p. 336, doi. 10.1111/j.1463-1326.2007.00712.x
- By:
- Publication type:
- Article
A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
- Published in:
- Diabetes, Obesity & Metabolism, 2005, v. 7, n. 5, p. 595, doi. 10.1111/j.1463-1326.2004.00455.x
- By:
- Publication type:
- Article
(Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Actions of prolonged glucagon-like peptide-1 receptor activation on cognitive function in a model of diet-induced obesity.
- Published in:
- Proceedings of the Nutrition Society, 2010, v. 69, n. OCE5, p. 12, doi. 10.1017/S0029665110002144
- By:
- Publication type:
- Article
A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice.
- Published in:
- Diabetologia, 2013, v. 56, n. 6, p. 1417, doi. 10.1007/s00125-013-2892-2
- By:
- Publication type:
- Article
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
- Published in:
- Diabetologia, 2007, v. 50, n. 8, p. 1752, doi. 10.1007/s00125-007-0710-4
- By:
- Publication type:
- Article
Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro<sup>3</sup>)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
- Published in:
- Diabetologia, 2007, v. 50, n. 7, p. 1532, doi. 10.1007/s00125-007-0692-2
- By:
- Publication type:
- Article
Effects of the novel (Pro<sup>3</sup>)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin V.A. Gault et al.: GIP receptor antagonist
- Published in:
- Diabetologia, 2003, v. 46, n. 2, p. 222, doi. 10.1007/s00125-002-1028-x
- By:
- Publication type:
- Article
Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP F.P.M. O'Harte et al.: Bioactive gastric inhibitory polypeptide analogues.
- Published in:
- Diabetologia, 2002, v. 45, n. 9, p. 1281, doi. 10.1007/s00125-002-0894-6
- By:
- Publication type:
- Article
N-terminally modified degradation resistant analogues of glucose-dependent insulinotropic polypeptide display enhanced antidiabetic action.
- Published in:
- Irish Journal of Medical Science, 2002, v. 171, p. 9, doi. 10.1007/BF03170226
- By:
- Publication type:
- Article
Receptor antagonist studies indicate that GIP is a more important enteroinsular axis hormone than GLP-1 in obese diabetic (OB/OB) mice.
- Published in:
- Irish Journal of Medical Science, 2002, v. 171, p. 18, doi. 10.1007/BF03170244
- By:
- Publication type:
- Article
Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
- Published in:
- International Journal of Obesity, 2013, v. 37, n. 5, p. 678, doi. 10.1038/ijo.2012.91
- By:
- Publication type:
- Article
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet.
- Published in:
- International Journal of Obesity, 2010, v. 34, n. 8, p. 1341, doi. 10.1038/ijo.2010.59
- By:
- Publication type:
- Article